Durvalumab vs Hydrochlorothiazide

Durvalumab vs Hydrochlorothiazide: Overview

This comparison examines the pharmacological differences between Durvalumab and Hydrochlorothiazide.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Hydrochlorothiazide: Inhibits Na+/Cl- cotransporter in distal convoluted tubule.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Hydrochlorothiazide — 6-15 hours.

Chemical Properties

Molecular Formula: Hydrochlorothiazide — C7H8ClN3O4S2.

Molecular Weight: Hydrochlorothiazide — 297.7400 g/mol.

Type: Durvalumab — Antibody; Hydrochlorothiazide — Small molecule.